S 1801 · 116th Congress 2019–2021, ended

Affordable Medications Act

Introduced Jun 12, 2019 Originated Senate Sponsor Tina Smith D-MN

Fact sheet Spreadsheet

Latest action · Jun 12, 2019 Read twice and referred to the Committee on Finance.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedJun 12, 2019
  2. Passed SenateNot reached
  3. Passed HouseNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Affordable Medications Act

This bill revises and expands various requirements relating to prescription-drug pricing and affordability. Specifically, the bill

  • expands financial reporting requirements for drug manufacturers and establishes corresponding civil penalties for noncompliance;
  • adds reporting requirements for certain nonprofit patient-assistance programs;
  • requires the Centers for Medicare & Medicaid Services (CMS) to negotiate prices for certain prescription drugs under Medicare;
  • requires the Centers for Medicare and Medicaid Innovation within the CMS to test specified models for negotiating drug prices;
  • establishes reporting requirements, and corresponding civil penalties for noncompliance, for pharmaceutical companies with respect to spikes in prescription-drug prices;
  • establishes an excise tax on prescription drugs subject to price spikes;
  • lessens prescription-drug cost-sharing requirements under qualified health plans and group health plans;
  • modifies requirements for the importation of prescription drugs;
  • requires drug manufacturers to provide drug rebates for drugs dispensed to certain low-income individuals under the Medicare program;
  • limits the time frame that trade agreements are required to provide market exclusivity for biological products;
  • establishes an innovation incentive fund for new or more effective treatments of bacterial infections;
  • establishes a Center for Clinical Research within the National Institutes of Health;
  • revises certain time frames and conditions related to drug exclusivity;
  • requires the Food and Drug Administration to establish a database of generic drugs; and
  • modifies other provisions related to generic drugs, prescription-drug advertising, disclosure of wholesale acquisition prices, and patent-infringement proceedings.

Cosponsors 15

Members who signed on, in the order they did. Signatures ran from Jun 12, 2019 to Sep 9, 2019; 14 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
D-MNAmy KlobucharOriginalJun 12, 2019
I-VTBernard SandersOriginalJun 12, 2019
D-NJCory A. BookerOriginalJun 12, 2019
D-MAElizabeth WarrenOriginalJun 12, 2019
D-RIJack ReedOriginalJun 12, 2019
D-ORJeff MerkleyOriginalJun 12, 2019
D-NYKirsten E. GillibrandOriginalJun 12, 2019
D-NHMargaret Wood HassanOriginalJun 12, 2019
D-CTRichard BlumenthalOriginalJun 12, 2019
D-ILRichard J. DurbinOriginalJun 12, 2019
D-RISheldon WhitehouseOriginalJun 12, 2019
D-OHSherrod BrownOriginalJun 12, 2019
D-WITammy BaldwinOriginalJun 12, 2019
D-NMTom UdallOriginalJun 12, 2019
D-CAKamala D. HarrisSep 9, 2019

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
SenateFinance Committee
Referred Jun 12, 2019

Actions 2

Everything that happened, newest first.

  1. Jun 12, 2019Introduced in Senate
  2. Jun 12, 2019Read twice and referred to the Committee on Finance.

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

CRS reports 2

Congressional Research Service work that CRS links to this bill or the law it became, newest first.

Cite it 2

Products on other subjects that cite it, usually among other measures.

Related bills 12

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
S 64Preserve Access to Affordable Generics and Biosimilars ActRelated billJan 9, 2019
S 73End Taxpayer Subsidies for Drug Ads ActRelated billJan 10, 2019
S 97Affordable and Safe Prescription Drug Importation ActRelated billJan 10, 2019
S 378Stop Price Gouging ActRelated billFeb 7, 2019
HR 447Affordable and Safe Prescription Drug Importation ActRelated billJan 25, 2019
HR 1093Stop Price Gouging ActRelated billFeb 7, 2019
HR 1478Affordable Insulin Act of 2019Related billMar 1, 2019
HR 1506FAIR Generics ActRelated billApr 8, 2019
S 1785Fair AMP ActRelated billJun 11, 2019
S 1898Affordable Medications ActReintroduced BillMay 27, 2021
S 3411Affordable Medications ActReintroduction ofSep 5, 2018
HR 8399End Taxpayer Subsidies for Drug Ads ActRelated billSep 25, 2020

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
A bill to ensure medications are affordable.
Short Title(s) as Introduced
Affordable Medications Act

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Jun 12, 2019Introduced in Senate

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

$1 $5 $10

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.